We planned to analyse the expression of EGFR in the tumour in at least 50% of the cases under study, already foreseeing the difficulty of accessing this material since many patients undergo biopsy or undergo surgery in other services and then are referred to our centre for treatment. The gene discussed is EGFR; the disease is neoplasm.